1. Auton, F. (2004), “The advertising of pharmaceuticals direct‐to‐consumers: a critical review of the literature and debate”,International Journal of Advertising, Vol. 23 No. 1, pp. 5‐52.
2. Axelrod, A. and Moore, D. (2004), “Direct‐to‐consumer advertising: a classic case of cognitive dissonance”,DTC Perspectives, December, p. 28.
3. Edwards, J. (2005), “FDA: quality of DTC ads is in noticeable decline: director of drug marketing lays down law to industry execs”,Brandweek, Vol. 46 No. 18, May 2, p. 12.
4. Goetzl, I. and Teinowitz, D. (2002), “Drug ad pressure: DTC ads dodge bullet; no Thomas curbs; outlays may flatten”,Advertising Age, Vol. 73, May 6, p. 59.
5. McLinden, M., Sandino, J. and Willard, T. (2004), “Fast relief: the prescription generic Omeprazole DTC launch”,DTC Perspectives, March, pp. 44‐7.